• AFP Imaging (Elmsford, New York) reported receiving FDA clearance to market its NewTom VG cone beam computed tomography scanner. This dental imaging system provides the clinician with 3-D, radiographic images of the teeth and jaws along with patient comfort through flexible seating options. NewTom VG patients can now stand, sit, or remain in their wheel chairs while being scanned. AFP Imaging is a diagnostic imaging supplier for dental, medical and veterinary professionals.

• American Bio Medica (Kinderhook, New York) reports the launch of the Rapid STAT, an oral fluid point of collection test. The Rapid STAT combines the incubation benefits of the company’s OralStat oral fluid device with the company’s urine-based Rapid TOX cassette product platform. The Rapid STAT also uses the same sample handling procedure of the company’s OralStat EX product launched earlier this year. The Rapid STAT provides faster test results, making it ideal for those market applications, such as roadside testing, in which portability and time is crucial. In addition to these added benefits, the Rapid STAT provides even lower THC (marijuana) testing sensitivity. American Bio Medica is a biotechnology company that makes immunoassay diagnostic test kits.

• Avid Radiopharmaceuticals (Philadelphia) reported that enrollment has begun in a proof-of-concept phase I clinical trial investigating Avid’s development compound ¹⁸F-AV-133 for imaging patients with movement disorders, including Parkinson’s Disease and essential tremor, and dementias, including Dementia with Lewy Bodies and Alzheimer’s Disease. The compound, used with PET imaging, targets vesicular monoamine transporters (VMAT2) in the brain and may enable more accurate and earlier diagnosis of neurodegenerative diseases. This new imaging compound may thus lead to improved disease management for patients and their caregivers. Avid Radiopharmaceuticals is a molecular imaging company.

• Microlife USA (Dunedin, Florida) reported the launch of the Microlife blood pressure monitoring and Peak Flow/FEV₁ monitoring drivers as a part of Microsoft’s newly launched consumer health platform, Microsoft HealthVault, to provide consumers with a new way to manage their health at home. The online environment allows consumers to search and connect people with their stored health information, putting them in greater control of their health and wellness. Microlife’s contribution includes the manufacture and support of clinically validated, hospital accurate blood pressure monitors and digital electronic Peak Flow/FEV₁ meters.